Minister Gonzalez visited LIF. He had a meeting with LIF’s Board of Directors and explored the new building sites for drugstore, and also research and development area.
Health Minister of Santa Fe Province and LIF’s President visited LIF where he explored the new building area for research and development. This project includes a new area where LIF will be able to develop and produce four medicines to treat patients with tuberculosis disease.
The project will require the investment of more than $21 million (ARG) of which $9.4 million (ARG) will be contributed by National Ministry of Innovation, Science and Technology through a FONARSEC* and the rest [$12.268.273,2.- (ARG)] will be contributed by LIF.
Since 2014, new equipments and machines were incorporated for this project such as: FT NIR; weighing scales; HPLC; PH meter; polarimeter, titration equipment; two analytic shakers; film coating; blister-packed; mixer double cone; rotary tablet press machine and a metal detector for tablets. This required an investment of $7.915.970.- (ARG).
Objective
The main objective of this project is that LIF will be able to develop and then produce four different medicines to treat patients with tuberculosis disease such as: Rifampicin + Isoniazid + Pyrazinamide (triple association); Ethambutol; Rifampin + Isoniazid (double association) and Isoniazid.
New building site for DIF.
The new building site for storage was also explored by the group. This is a new site for DIF(1) area.
After these activities LIF’s Board of Directors, General Manager, Trustee and Miguel Gonzalez had a meeting where they provided information about the production of metformin by the National Health Ministry. About that, LIF delivered in time 1.725.720 tablets of metformin of 10.100.100 tablets. This was the first delivery of six.
Carlos Arques, Diego Bruno, Jorge Stettler and Guillermo Cleti (LIF’s Board of Directors); Guillermo Álvarez (LIF’s Trustee); Roberto Ganin (LIF’s General Manager) and Santiago Torales (Provincial Director of Quality and Sanitary Assessment) participated in these activities.
*FONARSEC: Fondo Argentino Sectorial. It is a financial instrument through which an institution can improve its capacity of production.
(1)DIF: Droguería Industrial Farmacéutica - Pharmaceutical Industry Drugstore.
Health Minister of Santa Fe Province and LIF’s President visited LIF where he explored the new building area for research and development. This project includes a new area where LIF will be able to develop and produce four medicines to treat patients with tuberculosis disease.
The project will require the investment of more than $21 million (ARG) of which $9.4 million (ARG) will be contributed by National Ministry of Innovation, Science and Technology through a FONARSEC* and the rest [$12.268.273,2.- (ARG)] will be contributed by LIF.
Since 2014, new equipments and machines were incorporated for this project such as: FT NIR; weighing scales; HPLC; PH meter; polarimeter, titration equipment; two analytic shakers; film coating; blister-packed; mixer double cone; rotary tablet press machine and a metal detector for tablets. This required an investment of $7.915.970.- (ARG).
Objective
The main objective of this project is that LIF will be able to develop and then produce four different medicines to treat patients with tuberculosis disease such as: Rifampicin + Isoniazid + Pyrazinamide (triple association); Ethambutol; Rifampin + Isoniazid (double association) and Isoniazid.
New building site for DIF.
The new building site for storage was also explored by the group. This is a new site for DIF(1) area.
After these activities LIF’s Board of Directors, General Manager, Trustee and Miguel Gonzalez had a meeting where they provided information about the production of metformin by the National Health Ministry. About that, LIF delivered in time 1.725.720 tablets of metformin of 10.100.100 tablets. This was the first delivery of six.
Carlos Arques, Diego Bruno, Jorge Stettler and Guillermo Cleti (LIF’s Board of Directors); Guillermo Álvarez (LIF’s Trustee); Roberto Ganin (LIF’s General Manager) and Santiago Torales (Provincial Director of Quality and Sanitary Assessment) participated in these activities.
*FONARSEC: Fondo Argentino Sectorial. It is a financial instrument through which an institution can improve its capacity of production.
(1)DIF: Droguería Industrial Farmacéutica - Pharmaceutical Industry Drugstore.
No comments:
Post a Comment